strive inc /us/ - ASST
ASST
Close Chg Chg %
20.80 0.24 1.13%
Open Market
21.04
+0.24 (1.13%)
Volume: 2.88M
Last Updated:
Nov 3, 2026, 2:06 PM EDT
Company Overview: strive inc /us/ - ASST
ASST Key Data
| Open $21.43 | Day Range 20.82 - 21.60 |
| 52 Week Range 7.02 - 34.40 | Market Cap $2.83B |
| Shares Outstanding 127.33M | Public Float 115.64M |
| Beta 13.31 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$19.10 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 8.97M |
ASST Performance
| 1 Week | -6.29% | ||
| 1 Month | -30.74% | ||
| 3 Months | 87.22% | ||
| 1 Year | -21.80% | ||
| 5 Years | N/A |
ASST Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
5
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 41.00 | |
| Number of Ratings | 5 | Current Quarters Estimate | 2.603 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | -0.605 | |
| Last Quarter’s Earnings | 2.71 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -8.07 | Next Fiscal Year Estimate | 1.353 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 2 | 4 | 3 |
| Mean Estimate | 2.60 | 0.65 | -0.61 | 1.35 |
| High Estimates | 8.89 | 1.40 | 11.06 | 5.06 |
| Low Estimate | -0.21 | -0.10 | -8.73 | -0.71 |
| Coefficient of Variance | 165.21 | 163.18 | -1,480.72 | 237.70 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Strive Inc /us/ - ASST
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Strive Inc /us/ - ASST
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 6, 2026 | James A. Lavish Director | 8,815 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.76 per share | 271,149.40 |
| Oct 6, 2026 | Benjamin Pham Chief Financial Officer; Director | 17,365 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.33 per share | 544,045.45 |
| Oct 6, 2026 | Jonathan R. Macey Director | 8,115 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.32 per share | 246,046.80 |
| Oct 6, 2026 | Matthew Cole Chief Executive Officer; Director | 763,012 | Bona fide gift | 0.00 |
| Oct 6, 2026 | Matthew Cole Chief Executive Officer; Director | 844,795 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.33 per share | 26,467,427.35 |
| Oct 6, 2026 | Arshia Sarkhani Chief Marketing Officer; Director | 11,795 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.33 per share | 369,537.35 |
| Oct 6, 2026 | Brian Logan Beirne Chief Legal Officer; Director | 41,425 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.33 per share | 1,297,845.25 |
| Oct 5, 2026 | Pierre Rochard Director | 9,878 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 5, 2026 | H. Eric Semler Director | 21,824 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 5, 2026 | Arshia Sarkhani Chief Marketing Officer; Director | 25,926 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 5, 2026 | Brian Logan Beirne Chief Legal Officer; Director | 64,816 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 5, 2026 | Shirish Jajodia Director | 9,878 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 5, 2026 | Shirish Jajodia Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 5, 2026 | Shirish Jajodia Director | 14,815 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 5, 2026 | Mahesh Ramakrishnan Director | 9,878 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 5, 2026 | Mahesh Ramakrishnan Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 5, 2026 | Mahesh Ramakrishnan Director | 14,815 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 5, 2026 | Jonathan R. Macey Director | 9,878 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 5, 2026 | Jonathan R. Macey Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Oct 5, 2026 | James A. Lavish Director | 9,878 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |